From Paris to Policy: The Forces Reshaping Skincare Ingredients in 2026

From Paris to Policy: The Forces Reshaping Skincare Ingredients in 2026

This spring has delivered a cascade of developments that will define the next generation of skincare formulations. A landmark ingredient expo in Paris, pivotal regulatory decisions in the EU and Asia, and the rapid ascent of NAD+ in topical science signal that 2026 is a turning point for anyone paying attention to what goes into a formula — and what regulators will allow to stay.

In-Cosmetics Global 2026 Draws 16,000+ to Paris

The personal-care ingredient world convened in Paris this April for In-Cosmetics Global 2026, themed “Science at the Core, Beauty Reborn.” Over 1,100 exhibitors and 16,000 professionals explored advances in botanical extraction, biotech-derived actives, and sustainable delivery systems. Notably, Chinese botanical innovation took center stage — Botanee’s Yunnan Specialty Plant Lab presented highland botanical extracts that blend traditional knowledge with modern extraction precision, underscoring the growing global appetite for region-specific plant science.

ICIC 2026 Shanghai: Anti-Aging Science Takes the Lead

The International Cosmetics Innovation Conference (ICIC) gathered nearly 300 experts and 3,200 industry professionals in Shanghai this April for 24 themed forums. Anti-aging science dominated the agenda, with presentations on novel peptide delivery, plant-cell culture actives, and biomimetic barrier-repair strategies. The conference reinforced a clear industry pivot: from marketing-driven claims toward data-backed formulation science.

EU SCCS Issues Final Opinion on CBD in Cosmetics

On April 24, 2026, the EU Scientific Committee on Consumer Safety (SCCS) published its final opinion on Cannabidiol (CBD) used in cosmetic products. The opinion provides clarity on safe concentration limits and purity specifications, a milestone for brands formulating with hemp-derived actives. This decision will shape CBD product development across Europe and influence regulatory frameworks in other regions.

South Korea Updates Cosmetic Ingredient Analytical Methods

South Korea’s National Institute of Food and Drug Safety Evaluation (NIFDS) released a draft revision adding 18 new analytical methods for restricted cosmetic ingredients, alongside improved test protocols for triclosan and zinc pyrithione. The public comment period closed April 24, 2026. Enhanced analytical precision means tighter compliance enforcement — formulators targeting the Korean market should audit their testing procedures now.

NAD+ Emerges as the Breakout Skincare Ingredient of 2026

Nicotinamide adenine dinucleotide (NAD+) is generating serious scientific buzz this year. Independent reviews, including Dr. Sam’s Flawless Moisturiser Intense analysis on Doctor Anne, are examining whether NAD+ in topical formulations goes beyond basic barrier repair to genuinely influence cellular energy pathways in skin. While clinical consensus is still forming, the volume of new product launches featuring NAD+ — from serums to moisturizers — signals that this molecule has moved from niche research into mainstream formulation pipelines.

What These Signals Mean Together

• Botanical science is globalizing: Region-specific plant extracts (Yunnan, Amazonian, African) are moving from ethnobotanical curiosity into validated, scalable ingredient pipelines.
• Regulatory landscapes are tightening in parallel: The EU CBD opinion and Korea’s analytical updates show that regulators are keeping pace with ingredient innovation — and formulators must too.
• Cellular-energy ingredients are the new frontier: NAD+ follows niacinamide and retinol as the latest “cellular-level” active to cross from biomedical research into consumer skincare.